TIDMINHC
RNS Number : 4993W
Induction Healthcare Group PLC
26 April 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Multiple new hospital contracts for Induction Zesty
Additional pipeline of hospital trusts in South East England
look to deploy Induction digital solutions for patients
Induction (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, announces
that it has signed contracts with three prominent hospitals across
South East England to deploy Induction Zesty to deliver their
digital patient portals. The contracts are worth a total of
GBP440,000 covering time periods that range between 12 to 20
months.
James Balmain, Induction Joint CEO, said:
"This achievement is a result of true collaboration with our
multiple NHS partners, and its success will be a real watershed
moment in terms of how Induction can facilitate consistent, easy
and valuable engagements between patients and regional healthcare
systems. These new contract awards reinforce the strong momentum in
sales and annual recurring revenue run-rate already announced in
the second half of the financial year to 31 March 2021."
About Induction Zesty
Induction Zesty is a digital front door for hospitals, with an
intuitive interface that empowers patients to take control of their
appointments, correspondence and clinical records from the
convenience of their smartphone.
In March 2020, registered users of Induction Zesty had more than
doubled from 32,000 to 76,000 in one year. In the subsequent 12
months, Induction Zesty saw exponential growth to reach over
220,000 users today. With more than 700 new patient registrations
daily, this number will continue its climb unabated; the user base
increases as new hospitals use the platform and hospital activity
is returning to pre-pandemic levels.
Induction Zesty is employed by several NHS Trusts across the UK,
including The Royal Free London NHS Foundation Trust, a Global
Digital Exemplar, and Milton Keynes University Hospital NHS Trust,
with whom Induction has been working for three years. Data from
Milton Keynes show that 97% of patients report that Induction Zesty
provides easy registration, and 85% say they prefer having online
control over their appointments.
For more information on Induction Zesty visit:
https://inductionhealthcare.com/zesty
-ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
Dr Hugo Stephenson, Joint Chief Executive
Officer
James Balmain, Joint Chief Executive
Officer
N+1 Singer (Nominated Adviser and Broker) +44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd +44 (0)20 7933 8780
Paul McManus / Alice Woodings
About Induction - https://inductionhealthcare.com
Induction (AIM: INHC) is a leading virtual care platform driving
digital transformation of healthcare systems worldwide. Induction
solutions enhance the investments hospitals have made and lay the
foundation for their future. Our products can enable information
share between busy doctors, alleviate operational burdens on
hospitals or put patients in better control of their care, all
while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the
limitations of paper-based and desktop systems, creating massive
time and cost efficiencies.
More than 225,000 hospital doctors across multiple territories,
including the UK, Ireland, Australia and South Africa, as well as a
rapidly growing number of more than 220,000 UK patients, choose
Induction solutions.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps to increase productivity and enhance communication by
securely sharing phone numbers and bleeps, bookmarks, documents and
messages in a clinical setting.
Induction Guidance provides medical organisations, including
most hospital trusts within the NHS, with the ability to
collaboratively create, edit, and publish their own local medical
guidelines in a secure and locally administrated environment. This
increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for
patients visiting hospitals. The platform allows patients to book
and access their appointments, read their clinical letters, store a
copy of their clinical record and provide data to their care teams
remotely. It is not just a compelling patient experience, but also
delivers significant cost benefits to hospitals.
Induction HealthStream is a proprietary data integration
platform that reads and writes patient demographic, appointment and
clinical record data between a growing number of hospital EHR
systems and the Induction platforms. This connectivity between
stakeholders and legacy IT systems adds substantial value to
pre-existing health IT investment and allows large-scale adoption
of Induction app-based services.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CNTIJMATMTATBIB
(END) Dow Jones Newswires
April 26, 2021 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024